CYTONOME/ST LLC

In News

Cytonome cell sorter aids in Parkinson’s treatment - bioinformant.com

bioinformant.com - Apr 06, 2021

Sumitomo Dainippon Pharma Co. Ltd. Chooses Cytonome's GigaSort® Cell Sorting Technology for Cell Bioprocessing - newswire.com

newswire.com - Apr 03, 2018

Think Before You Draft: Patent Prosecution Has Consequences For Patent Litigation - Hunton Andrews Kurth LLP

Hunton Andrews Kurth LLP - Dec 05, 2023

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - bioinformant.com

bioinformant.com - Mar 11, 2026

“A”/“An” Means “One or More,” Said the Federal Circuit…Again - Lexology

Lexology - Oct 25, 2023

Patent Filings Roundup: Lighthouse Campaign Snuffed Out, At Liberty to Sue, Express Train Rolls On - IPWatchdog.com

IPWatchdog.com - Sep 09, 2020

Fighting implicit bias in STEM with increased cognitive control - MIT News

MIT News - Jun 25, 2018

ASP Isotopes Appoints Heather Kiessling as Chief Financial Officer - citybiz.co

citybiz.co - Jun 13, 2024

Cytonome Licenses GigaSort Technology for Cell Therapy Manufacture - bioinformant.com

bioinformant.com - Jul 05, 2018

Interlocutory injunction Granted to Restrain Alleged Patent Infringement in New Zealand - Pearce IP

Pearce IP - Jan 17, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment